GLP-1 Muscle Loss — The Hidden Risk

GLP-1 Muscle Loss — Uncover the hidden risk with Dr. Ben Synth

35 s · 7 de abr de 2026
Portada del episodio GLP-1 Muscle Loss — Uncover the hidden risk with Dr. Ben Synth

Descripción

Join Dr. Ben Synth as he uncovers the hidden cost of GLP-1 drugs like Ozempic and Mounjaro—your muscle mass. Discover the science behind muscle loss, explore next-generation therapies to prevent it, and learn practical strategies to protect lean tissue while shedding pounds. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de GLP-1 Muscle Loss — The Hidden Risk!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

8 episodios

Portada del episodio GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic

GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic

Host Ben Synth examines research showing two-thirds of GLP-1 weight loss can be muscle, not fat. This episode covers evidence-based strategies to preserve muscle during Ozempic, Wegovy, or Mounjaro treatment: resistance training protocols, protein timing, hydration, and multidisciplinary care. Learn why exercise prevents weight regain after stopping medication. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202625 min
Portada del episodio GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202624 min
Portada del episodio GLP-1 Muscle Loss — The Hidden Risk - Uncover what your medication isn't telling you with Dr. Ben Synth

GLP-1 Muscle Loss — The Hidden Risk - Uncover what your medication isn't telling you with Dr. Ben Synth

Join Dr. Ben Synth as he uncovers the hidden truth behind GLP-1 weight loss drugs: you're not just losing fat, you're losing muscle. This eye-opening series reveals the science pharmaceutical companies don't advertise and breakthrough strategies involving protein optimization, training protocols, and futuristic therapies that could revolutionize sustainable weight loss. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7 de abr de 202634 s